期刊文献+

不同时间变应原暴露对大鼠哮喘模型的影响 被引量:3

Effect of exposure to allergen through different duration on a rat asthmatic model
下载PDF
导出
摘要 目的:研究幼年大鼠不同时间接触卵蛋白(ovalbumin,OVA)对成年后气道哮喘炎症的影响及机制。方法:新生SD(Sprague Dawley)大鼠随机分为哮喘组,出生后第3天、第7天、第14天变应原接触组,以及正常对照组。各变应原接触组分别于出生后第3天、第7天和第14天给予皮下注射OVA1 mg(含氢氧化铝凝胶5 mg)。大鼠饲养至6周龄后,除正常对照组外其他各组均经OVA致敏并激发为哮喘模型。观察大鼠肺组织病理改变,计数每个细支气管上皮中黏液细胞数量。检测脾及胸腺中CD4+CD25+T细胞比例和叉头框P3(forkhead box P3,Foxp3)转录因子mRNA表达水平。结果:出生后第3天组(2.29±0.49)、出生后第7天组(1.25±0.46)与哮喘组相比(3.50±0.76)黏液细胞数量减少(P<0.01),气道炎症明显减轻;而出生后第14天组黏液细胞数未见减少[(3.00±1.16)vs(3.50±0.76),P>0.05]。出生后第3天组、第7天组脾中CD4+CD25+T细胞比例[(13.68±3.54)%vs(7.33±3.39)%,P<0.01;(16.65±4.91)%vs(7.33±3.39)%,P<0.01]和Foxp3 mRNA水平[(18.46±5.01)vs(5.49±1.99),P<0.01;(26.37±4.68)vs(5.49±1.99),P<0.01]与正常组比较均明显升高,且出生后第7天组胸腺中Foxp3 mRNA表达亦增高[(18.73±3.66)vs(11.13±1.75),P<0.01];但出生后第14天组脾CD4+CD25+T细胞比例及Foxp3 mRNA表达与正常组比较差异均无统计学意义[(11.04±2.88)%vs(7.33±3.39)%,P>0.05;(8.71±2.19)vs(5.49±1.99),P>0.05]。结论:早期接触变应原对大鼠哮喘气道炎症的抑制作用存在"时间窗"现象,其发生机制可能与诱导产生调节性T细胞有关。 Objective : To investigate the effect of exposure to allergen ( ovalbumin, OVA) at different times in infancy on the asthmatic airway inflammation of adult rats, and its possible mechanisms. Methods: Newborn rats were classified as asthma model group, day 3, day 7, day 14 after birth allergen exposure groups and control group, and were injected with OVA 1 mg (containing aluminum hydroxide gel 5 mg) subcutaneously on days 3, 7 and 14 after birth respectively. When all rats were kept till six weeks old, all groups but the control group were immunized and provoked via OVA to make asthma model. The pathologic changes of lung tissue and the hyperplasia of mucous cells per bronchiole were observed. The percentage of CD4^+ CD25^+T cells and forkhead box P3 (Foxp3) transcription factor mRNA in the splenocytes and thymocytes were also measured. Results: The airway inflammation alleviated significantly and number of mucous cells per bronchiole decreased significantly in day 3 group [ (2. 29 ± 0.49) vs(3.50 ± 0.76),P〈0.01] and day7 group[(1.25 ±0.46) vs( 3.50 ± 0.76), P〈0.01] compared with asthma group. However, the hyperplasia of mucous cells did not alleviate significantly in day 14 group [ (3.00 ± 1.16) vs( 3.50 ±0. 76), P 〉0. 05]. The CD4^+CD25^+T cells and Foxp3 mR- NA in the splenocytes increased in day 3 group [ ( 13.68 ± 3.54 ) % vs (7.33 ± 3.39 ) %, P 〈 0. 01 ; (18.46±5.01) vs (5.49 ±1.99), P〈0.01] and day7 group [(16.65 ±4.91)% vs (7.33 ± 3.39 ) %, P 〈 0. 01 ; (26. 37 ± 4.68 ) vs ( 5.49 ± 1.99 ), P 〈 0.01 ] compared with control group, so did Foxp3 mRNA in thymus in day 7 group [ ( 18.73 ± 3.66) vs ( 11.13 ± 1.75 ), P 〈 0.01 ]. But neither the CD4^+ CD25 ^+ T cells [ ( 11.04 ± 2. 88 ) % vs (7.33 ±3.39 ) %, P 〉 0. 05 ] nor Foxp3 mRNA expression[ (8.71±2. 19) vs( 5.49 ± 1.99), P 〉 0. 05 ] had a statistically significant increase in day 14 group. Conclusion: There exists a "time-window" for inhibiting airway inflammation by early exposure to allergen in the rat asthma model. The possible mechanism could be associated with induced generation of regulatory T cells.
出处 《北京大学学报(医学版)》 CAS CSCD 北大核心 2008年第3期306-309,共4页 Journal of Peking University:Health Sciences
基金 国家自然科学基金资助项目(30740048)~~
关键词 哮喘 免疫耐受 T淋巴细胞 卵蛋白类 大鼠 Asthma Immune tolerance Regulatory T cells Egg proteins Rats
  • 相关文献

参考文献10

  • 1Cookson WO, Moffatt MF. Asthma: an epidemic in the absence of infection[J]. Science, 1997,275:41 -42.
  • 2Bonini S. The hygiene hypothesis: epidemiologic evidence[ J]. J Pediatr Gastroenterol Nutr, 2005,40 (Suppl 1 ) : 37 -38.
  • 3骆文玲,李海潮,郝洪军,宿利.早期接触过敏原对大鼠哮喘模型的影响[J].北京大学学报(医学版),2006,38(2):159-163. 被引量:7
  • 4Prescott SL, Macaubas C, Halt B J, et al. Transplacental priming of the human immune system to environmental allergns: universal skewing of initial T cell responses toward the Th2 cytokine profile [J]. J Immunol, 1998,160:4730-4737.
  • 5Riedler J, Eder W, Oberfeld G, et al. Austrian children living on a farm have less hay fever, asthma and allergic sensitization [ J ]. Clin Exp Allergy, 2000,30 : 194 - 200.
  • 6Bluestone JA, Abbas AK. Natural versus adaptive regulatory T ceils [ J ]. Nat Rev Immuno1,2003 ,3 :253 - 257.
  • 7Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FOXP3 [ J ]. Science, 2003, 299 : 1057 - 1061.
  • 8Robinson DS, Larche M, Durham SR. Tregs and allergic disease [J]. J Clin Invest, 2004,114:1389 - 1397.
  • 9Thornton CA, Upham JW, Wikstrom ME, et al. Functional maturation of CD4^+ CD25^+ CTLA4^+ CIM5RA^+ T regulatory ceils in human neonatal T cell responses to environmental antigens/allergens [ J ]. J Immunol, 2004,173 : 3084 - 3092.
  • 10Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self tolerance maintained by activated T ceils expressing IL-2 receptor α-chains[J]. J Immunol, 1995,155 : 1151 - 1164.

二级参考文献17

  • 1Macaubas C,DeKruyff RH,Umetsu DT.Respiratory tolerance in the protection against asthma[J].Curr Drug Targets Inflamm Allergy,2003,2:175-186.
  • 2Karol MH.Animal models of occupational asthma[J].Eur Respir J,1994,7:555-568.
  • 3Manzolli S,Macedo-Soares MF,Vianna EO,et al.Allergic inflammation in hypothyoid rats[J].J Allergy Clin Immunol,1999,104:595-600.
  • 4de Sousa-Mucida D,de Castro-Keller A,Fernvik EC,et al.Unconventional strategies for the suppression of allergic asthma[J].Curr Drug Targets Inflamm Allergy,2003,2:187-195.
  • 5Kumar RK,Herbert C,Webb DC,et al.Effects of anticytokine therapy in a mouse model of chronic asthma[J].Am J Respir Crit Care Med,2004,170:1043-1048.
  • 6Steinke JW.Anti-interleukin-4 therapy[J].Immunol Allergy Clin North Am,2004,24:599-614.
  • 7Henderson WR Jr,Chi EY,Maliszewski CR.Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma[J].J Immunol,2000,164:1086-1095.
  • 8Shirota H,Sano K,Kikuchi T,et al.Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator[J].J Immunol,2000,164:5575-5582.
  • 9Rolinck-Werninghaus C,Wahn U,Hamelmann E.Anti-IgE therapy in allergic asthma[J].Curr Drug Targets Inflamm Allergy,2005,4:551-564.
  • 10Chung Y,Cho J,Chang YS,et al.Preventive and therapeutic effects of oral tolerance in a murine model of asthma[J].Immunobiology,2002,206:408-423.

共引文献6

同被引文献20

  • 1槐丽苹,刘辉,张楠,孙俊峰,王云英,魏辉.不同粒径氢氧化铝佐剂对白喉类毒素免疫效果的影响[J].微生物学免疫学进展,2011,39(3):15-17. 被引量:6
  • 2田代印,符州,张燕,王莉佳,迟磊,李睿,戴继宏,罗晓菊.一种改良型小鼠哮喘模型方法的建立及评价[J].重庆医科大学学报,2005,30(4):601-603. 被引量:27
  • 3骆文玲,李海潮,郝洪军,宿利.早期接触过敏原对大鼠哮喘模型的影响[J].北京大学学报(医学版),2006,38(2):159-163. 被引量:7
  • 4王勇生,桂淑玉,李永怀.过敏性哮喘大鼠模型的建立及地塞米松对其的影响[J].中国医药导报,2007,4(08S):39-41. 被引量:13
  • 5Li R, Yang X, Wang L, et al. Respiratory syncytial virus infection reversed anti-asthma effect of neonatal Bacillus Calmette-Guerin Vaccination in BALB/C mice[ J]. Pediatr Res ,2006,59:210 -215.
  • 6Wang Y, Mccusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: development of tol- erance using environmental antigens [ J ]. J Allergy Clin Immunol, 2006,118 : 143 - 151.
  • 7Renz H, Blumer N, Virna S, et al. The immunological basis of the hygiene hypothesis [ J ]. Chem Immunol Allergy,2006,91:30 - 48.
  • 8Bonini S. The hygiene hypothesis : epidemiologic evidence [ J ]. J Pediatr Gastroenterol Nutr,2005,40( suppl 1) :37 -38.
  • 9Fang SP,Tanaka T, Tago F, et al. Immunomodulatory effects of gyokuheifusan on IFN-gamma/Il-4 (Th1/Th2) balance in ovalbu- min(OVA)-induced asthma model mice [ J]. Biol Pharm Bull, 2005,28 : 829 - 833.
  • 10Sakai K, Yokoyama A, Kohno N, Effect of different sensitizing doses of antigen in a murine model of atopic asthma. Clin Exp Immunol, 1999, 118:9-15.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部